XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 228,610 $ 238,947
Marketable securities 89,438 71,601
Accounts receivable, net 174,693 179,525
Inventory 31,276 32,332
Prepaid expenses and other current assets 15,243 15,195
Total current assets 539,260 537,600
Property and equipment, net 15,457 15,983
Operating lease assets 5,813 6,029
Intangible assets, net 387,191 421,708
Restricted cash 1,047 1,047
Deferred tax assets 30,671 26,259
Other noncurrent assets 954 825
Goodwill 133,857 133,857
Total assets 1,114,250 1,143,308
Current liabilities    
Accounts payable 6,020 8,692
Accrued liabilities 38,190 37,571
Accrued rebates, returns and discounts 217,880 227,331
Current portion of term notes payable 183,333 183,333
Current portion of operating lease liabilities 1,013 988
Total current liabilities 446,436 457,915
Term notes payable, net of current portion 177,360 221,713
Convertible senior notes 262,425 262,125
Operating lease liabilities, net of current portion 5,860 6,124
Total liabilities 892,081 947,877
Commitments and contingencies (refer to Note 14)
Shareholders' equity:    
Preferred stock, $0.001 par value; authorized shares - 5,000,000
Common stock, $0.001 par value; authorized shares - 100,000,000; 39,029,639 issued and 32,705,747 outstanding shares as of March 31, 2024 and 38,192,441 issued and 31,868,549 outstanding shares as of December 31, 2023 39 38
Additional paid-in capital 565,111 565,949
Treasury stock, at cost; 6,323,892 shares as of March 31, 2024 and 6,323,892 shares as of December 31, 2023 (137,381) (137,381)
Accumulated other comprehensive (loss) income (124) 14
Accumulated deficit (205,476) (233,189)
Total shareholders' equity 222,169 195,431
Total liabilities and shareholders' equity $ 1,114,250 $ 1,143,308